Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen to Go Commercial With Macdonald

Premium

David Macdonald’s come a long way from building weapons systems. After his start at Raytheon in his native Boston, he ventured into science and hasn’t left since. Now senior vice president of operations at Nanogen, Macdonald says his job will be “taking the technologies that have been developed here over the past eight years and turning them into products that we can commercialize.” Nanogen will be a leader in making routine clinical molecular diagnostics, he believes; it’s just a matter of selling.

Formerly president of two linked San Diego startups — one in animal fertility, one in human — Macdonald decided not to relocate when the firms moved to Israel. For about eight years before that, he headed up the Nichols Institute diagnostics division, which Corning bought and spun out as Quest Diagnostics.

Eager to stay in the San Diego area, “I sent a letter to Nanogen and they were intrigued by my background,” says Macdonald, who will focus on getting market share away from homebrew tests to carve out a niche for his company’s products.

— Meredith Salisbury

 

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.